Patents by Inventor Frank Emmert-Streib

Frank Emmert-Streib has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9892229
    Abstract: The invention provides a method of defining the likelihood of a subject having bladder cancer, comprising the steps of: (A) assessing the subject's likelihood of having bladder cancer by: i. identifying at least one sub-population group appropriate to the subject; ii. determining the level of one or more biomarkers selected according to the sub-population group in a sample obtained from the subject; iii. inputting each of the biomarker values into an algorithm to produce an output value; and iv. correlating the output value with the likelihood of the subject having bladder cancer, wherein the sub-population group is selected according to smoking habits, gender, presence/absence of stone disease, history of benign prostate enlargement (BPE) or prescription of anti-hypertensive, anti-platelet and/or anti-ulcer medication, and (B) determining the subject's stratified risk level of serious disease by: v.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: February 13, 2018
    Assignee: RANDOX LABORATORIES LTD.
    Inventors: Mark William Ruddock, Cherith N. Reid, Kate E. Williamson, Frank Emmert-Streib, John V. Lamont, Peter Fitzgerald
  • Publication number: 20150269311
    Abstract: The invention provides a method of defining the likelihood of a subject having bladder cancer, comprising the steps of: (A) assessing the subject's likelihood of having bladder cancer by: i. identifying at least one sub-population group appropriate to the subject; ii. determining the level of one or more biomarkers selected according to the sub-population group in a sample obtained from the subject; iii. inputting each of the biomarker values into an algorithm to produce an output value; and iv. correlating the output value with the likelihood of the subject having bladder cancer, wherein the sub-population group is selected according to smoking habits, gender, presence/absence of stone disease, history of benign prostate enlargement (BPE) or prescription of anti-hypertensive, anti-platelet and/or anti-ulcer medication, and (B) determining the subject's stratified risk level of serious disease by: v.
    Type: Application
    Filed: October 16, 2013
    Publication date: September 24, 2015
    Inventors: Mark William Ruddock, Cherith N. Reid, Kate E. Williamson, Frank Emmert-Streib, John V. Lamont, Peter Fitzgerald